1073-P: Trends in Guideline-Directed Medication Therapy for Type 2 Diabetes in a Statewide Quality Collaborative between 2018–2023

Introduction and Objective: Since 2021, the Michigan Collaborative for Type 2 Diabetes (MCT2D) aims to improve guideline-directed medication therapies (GDMT) for type 2 diabetes (T2D). We examined trends in glucagon-like peptide-1 receptor agonist (GLP-1RA) and sodium-glucose transport protein 2 inh...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes (New York, N.Y.) N.Y.), 2024-06, Vol.73 (Supplement_1), p.1
Hauptverfasser:	MIZOKAMI-STOUT, KARA R., OSHMAN, LAUREN, DIEZ, HEIDI L., GRIAUZDE, DINA H., LEE, JOYCE M., KHOSROVANEH, KATHERINE L., BHOMIA, NEHA, KIM, NOA, RAU, JACQUELINE, REISS, JACOB, BUSUI, RODICA
Format:	Artikel
Sprache:	eng
Schlagworte:	Collaboration Diabetes Diabetes mellitus (non-insulin dependent) Drug therapy Endocrinology GLP-1 receptor agonists Glucagon Glucagon-like peptide 1 Glucose transport Pharmacy Primary care Protein transport Trends
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!